AANA Applauds Addition of CRNAs To SAMHSA Practitioner List
This final rule was an update from an original rule proposed in
"We applaud SAMHSA for its decision to include CRNAs in the definition of practitioner as it supports practitioner autonomy and creates a patient-centered view while reducing barriers to OUD care," said AANA President
CRNAs, as professionals in the science of nurse anesthesiology, work in rural and underserved communities where the need to decrease reliance on opioids is great. CRNAs have been on the front lines of developing novel non-opioid based treatments for both chronic and acute pain, and AANA supports maximum flexibility in allowing pain treatment plans that rely on the clinical judgment of the practitioner directing care. CRNAs are chronic pain management practitioners, managing pain through a multimodal approach that includes opioid-sparing or non-opioid pharmacologic and non-pharmacologic pain mitigation strategies.
"As a main provider of pain management services, CRNAs are uniquely skilled to provide both acute and chronic pain management in a patient-centered, compassionate, and holistic manner," said Riddle. "As members of one of America's most trusted professions, CRNAs have always served on the front lines of patient care from the beginning, and we continue to answer the call to help keep patients healthy and safe."
View original content to download multimedia:https://www.prnewswire.com/news-releases/aana-applauds-addition-of-crnas-to-samhsa-practitioner-list-302071559.html
SOURCE American Association of Nurse Anesthesiology
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InventHelp Inventor Develops New Courtesy Sign for Vehicles (CBA-4008)
- Asian School of Design & Applied Vastu Launches Global Operations, Appoints Shantanu Pandey as Director
- Axi Select Hosts Exclusive Madrid Gathering for Pro M Traders and Axi Leadership
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share